Cowen Financial Products LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 11:26 am Sale | 2025-09-30 | 13G | UROGEN PHARMA LTD URGN | Cowen Financial Products LLC | 0 0.000% | -3,190,510 (Position Closed) | Filing |
| 2025-07-29 4:56 pm Purchase | 2025-06-30 | 13G | UROGEN PHARMA LTD URGN | Cowen Financial Products LLC | 3,190,510 6.900% | 538,010 (+20.28%) | Filing |
| 2025-06-13 11:38 am Purchase | 2025-06-09 | 13G | UROGEN PHARMA LTD URGN | Cowen Financial Products LLC | 2,652,500 5.800% | 2,652,500 (New Position) | Filing |